Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | MNPR | ENGN | ||
| Company | Urovant Sciences Ltd | Monopar Therapeutics Inc | Engene Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.23 | 80.40 | 8.10 | ||
| High | 16.24 | 83.87 | 8.21 | ||
| Low | 16.21 | 75.27 | 7.77 | ||
| Latest | 16.24 | 77.49 | 8.34 | ||
| Change | +0.01 | -2.89 | +0.27 | ||
| % Change | +0.06% | -3.60% | +3.35% | ||
| Volume | 1,739,000 | 176,280 | 214,301 | ||
| 20-Day Average Volume | 143,510 | 167,344 | 3,269,465 | ||
| Previous Close | 16.23 | 80.38 | 8.07 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 82.90 | 7.77 | ||
| 20-Day Raw Stochastic | 87.10% | 16.72% | 44.12% | ||
| 20-Day Relative Strength | 65.56 | 47.76 | 55.25 | ||
| Weighted Alpha | +6.45 | +89.58 | +28.39 | ||
| Today's Opinion | 100% Buy | 48% Buy | 96% Buy | ||
| Previous Opinion | 100% Buy | 48% Buy | 80% Buy | ||
| Last Month's Opinion | 96% Buy | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | -5.57% since 12/01/25 | +3.48% since 12/01/25 | ||
| Low | 16.20 on 03/24/21 | 74.00 on 12/03/25 | 7.65 on 12/03/25 | ||
| High | 16.25 on 03/25/21 | 85.01 on 12/05/25 | 8.28 on 12/02/25 | ||
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | -3.11% since 11/07/25 | +35.07% since 11/07/25 | ||
| Low | 16.10 on 03/02/21 | 74.00 on 12/03/25 | 5.85 on 11/10/25 | ||
| High | 16.26 on 03/19/21 | 100.50 on 11/24/25 | 11.14 on 11/11/25 | ||
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | +89.08% since 09/08/25 | +50.74% since 09/08/25 | ||
| Low | 16.03 on 12/30/20 | 41.67 on 09/09/25 | 5.06 on 09/09/25 | ||
| High | 16.26 on 03/19/21 | 105.00 on 10/06/25 | 11.14 on 11/11/25 | ||
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | +111.34% since 06/06/25 | +116.53% since 06/06/25 | ||
| Low | 7.15 on 11/02/20 | 29.18 on 08/26/25 | 2.90 on 06/12/25 | ||
| High | 16.26 on 03/19/21 | 105.00 on 10/06/25 | 11.14 on 11/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 537,147 | 521,144 | ||
| Shares Outstanding, K | 32,743 | 6,683 | 64,578 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -146,750,000 | -15,590,000 | -55,140,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -46,800,000 | -3,440,000 | -28,990,000 | ||
| 60-Month Beta | 2.35 | 1.46 | -0.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.48 on 11/13/25 | -0.57 on 09/11/25 | ||
| Latest Earnings Date | 02/11/21 | 11/14/25 | 12/18/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 12/24/14 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||